Two Sigma Investments’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
Two Sigma Investments's FLNA Position: Q1 2026 in Review
Two Sigma Investments increased its Filana Therapeutics (FLNA) stake by 210% in Q1 2026, buying an estimated $2.77M and bringing the position to 1,988,814 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2348.
Two Sigma Investments first reported a position in FLNA in Q4 2013 and has held it in 15 quarters since. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Two Sigma Investments held 1,988,814 shares of Filana Therapeutics worth $3.36M as of Q1 2026.
- Two Sigma Investments bought 1,346,413 Filana Therapeutics shares in Q1 2026, an estimated $2.77M.
- Filana Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2348 holding.
- Two Sigma Investments first reported a position in Filana Therapeutics in Q4 2013 and has held it in 15 quarters since.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.